GRPR and posterior cortical atrophy: Two major factors played a significant role in revitalizing interest in introducing GRPR-based diagnostics for PCa: Firstly, the development of radioligands occurs based on GRPR antagonists, which do not trigger side effects and do not provoke GRPR downregulation since they do not activate the GRPR [21,34,35,36,37].